Skip to main content

Table 2 Markers of disease progression and outcome study group.

From: Severe anaemia is not associated with HIV-1 env gene characteristics in Malawian children

  Cases Controls p
Wasting (Z-score weight for height <-2) 7/36 (19%) 5/38 (13%) 0.46
Previous hospital admission 25/44 (57%) 16/41 (39%) 0.10
Mortality (18 months) 27/45 (60%) 6/41 (15%) <0.001
   During admission 7/45 (16%) 0/41 (0%) 0.01
   After discharge 20/38 (53%) 6/41 (15%) <0.001
Plasma viral load (mean ± SD in Log10/mL) 6.02 ± 1.08 n = 13 5.43 ± 0.85 n = 12 0.15
Severe immunodeficient (based on CD4%*) 9/16 (56%) 5/12 (42%) 0.45
  1. Markers of disease progression in children with severe anaemia (cases Hb<5.0 g/dL) as compared to those without severe anaemia (controls). SD: Standard deviation; Viral loads were performed using a in-house methods as described in the method section. *According to the revised WHO guidelines CD4 <25% (6–12. months); <20% (12–35 months); <25% (36–59 months) [40].